These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20926592)

  • 1. Limited utility of oral glucose tolerance test in biochemically active acromegaly.
    Ribeiro-Oliveira A; Faje AT; Barkan AL
    Eur J Endocrinol; 2011 Jan; 164(1):17-22. PubMed ID: 20926592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly.
    Carmichael JD; Bonert VS; Mirocha JM; Melmed S
    J Clin Endocrinol Metab; 2009 Feb; 94(2):523-7. PubMed ID: 19033371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic tests and basal values for defining active acromegaly.
    Tzanela M
    Neuroendocrinology; 2006; 83(3-4):200-4. PubMed ID: 17047383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity.
    Elias PC; Lugao HB; Pereira MC; Machado HR; Castro Md; Moreira AC
    Horm Metab Res; 2010 Jan; 42(1):50-5. PubMed ID: 19798623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is GH nadir during OGTT a reliable test for diagnosis of acromegaly in patients with abnormal glucose metabolism?
    Dobri G; Niwattisaiwong S; Bena JF; Gupta M; Kirwan J; Kennedy L; Hamrahian AH
    Endocrine; 2019 Apr; 64(1):139-146. PubMed ID: 30415402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
    Colao A; Pivonello R; Cavallo LM; Gaccione M; Auriemma RS; Esposito F; Cappabianca P; Lombardi G
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):250-6. PubMed ID: 16886969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional and novel biomarkers of treatment outcome in patients with acromegaly: discordant results after somatostatin analog treatment compared with surgery.
    Rubeck KZ; Madsen M; Andreasen CM; Fisker S; Frystyk J; Jørgensen JO
    Eur J Endocrinol; 2010 Nov; 163(5):717-26. PubMed ID: 20813787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and hormonal findings in patients presenting with high IGF-1 and growth hormone suppression after oral glucose load: a retrospective cohort study.
    Carosi G; Mangone A; Sala E; Del Sindaco G; Mungari R; Cremaschi A; Ferrante E; Arosio M; Mantovani G
    Eur J Endocrinol; 2021 Jul; 185(2):289-297. PubMed ID: 34081617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly.
    Grottoli S; Razzore P; Gaia D; Gasperi M; Giusti M; Colao A; Ciccarelli E; Gasco V; Martino E; Ghigo E; Camanni F
    J Endocrinol Invest; 2003 Feb; 26(2):123-7. PubMed ID: 12739738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal and glucose-suppressed GH levels less than 1 microg/L in newly diagnosed acromegaly.
    Freda PU; Reyes CM; Nuruzzaman AT; Sundeen RE; Bruce JN
    Pituitary; 2003; 6(4):175-80. PubMed ID: 15237928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DISCORDANCE BETWEEN GH AND IGF-1 LEVELS IN TURKISH ACROMEGALIC PATIENTS.
    Cerit ET; Ağbaht K; Demir Ö; Şahin M; Gedik VT; Özcan C; Çorapçıoğlu D
    Endocr Pract; 2016 Dec; 22(12):1422-1428. PubMed ID: 27631850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of early postoperative random growth hormone levels and nadir growth hormone levels after oral glucose tolerance testing in acromegaly.
    Rotermund R; Burkhardt T; Rohani Z; Jung R; Aberle J; Flitsch J
    Growth Horm IGF Res; 2018 Aug; 41():64-70. PubMed ID: 29555234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ghrelin test for the assessment of GH status in successfully treated patients with acromegaly.
    Pekic S; Doknic M; Miljic D; Joksimovic M; Glodic J; Djurovic M; Dieguez C; Casanueva F; Popovic V
    Eur J Endocrinol; 2006 May; 154(5):659-66. PubMed ID: 16645012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly.
    Kim EH; Oh MC; Lee EJ; Kim SH
    Neurosurgery; 2012 May; 70(5):1106-13; discussion 1113. PubMed ID: 22067418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
    Costa AC; Rossi A; Martinelli CE; Machado HR; Moreira AC
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of oral glucose tolerance test (OGTT) 100 g with OGTT 75 g for evaluation of acromegalic patients and the impact of gender on test reproducibility.
    Arafat AM; Müller L; Möhlig M; Mayr B; Kremenevskaya N; Pfeiffer AF; Buchfelder M; Schöfl C
    Clin Endocrinol (Oxf); 2011 Nov; 75(5):685-91. PubMed ID: 21575028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender and age in the biochemical assessment of cure of acromegaly.
    Freda PU; Landman RE; Sundeen RE; Post KD
    Pituitary; 2001 Aug; 4(3):163-71. PubMed ID: 12138989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability of the oral glucose tolerance test in the early postoperative assessment of acromegaly remission.
    Kristof RA; Neuloh G; Redel L; Klingmüller D; Schramm J
    J Neurosurg; 2002 Dec; 97(6):1282-6. PubMed ID: 12507124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring disease activity using GH and IGF-I in the follow-up of 501 patients with acromegaly.
    Sherlock M; Aragon Alonso A; Reulen RC; Ayuk J; Clayton RN; Holder G; Sheppard MC; Bates A; Stewart PM
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):74-81. PubMed ID: 19178529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up.
    Dimaraki EV; Jaffe CA; DeMott-Friberg R; Chandler WF; Barkan AL
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3537-42. PubMed ID: 12161471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.